DE20116639U1 - Referenzstandards zur Bestimmung der Reinheit oder der Stabilität von Amlodipinmaleat - Google Patents

Referenzstandards zur Bestimmung der Reinheit oder der Stabilität von Amlodipinmaleat

Info

Publication number
DE20116639U1
DE20116639U1 DE20116639U DE20116639U DE20116639U1 DE 20116639 U1 DE20116639 U1 DE 20116639U1 DE 20116639 U DE20116639 U DE 20116639U DE 20116639 U DE20116639 U DE 20116639U DE 20116639 U1 DE20116639 U1 DE 20116639U1
Authority
DE
Germany
Prior art keywords
analysis result
mixture
amlodipine maleate
amlodipine
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE20116639U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
BIOORG BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE20116639(U1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BIOORG BV filed Critical BIOORG BV
Publication of DE20116639U1 publication Critical patent/DE20116639U1/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N2030/621—Detectors specially adapted therefor signal-to-noise ratio
    • G01N2030/625—Detectors specially adapted therefor signal-to-noise ratio by measuring reference material, e.g. carrier without sample
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8872—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample impurities
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt

Claims (3)

1. Zusammensetzung umfassend Amlodipinmaleat, herstellbar durch ein Verfah­ ren, das folgende Schritte umfaßt: das Vermischen von Amlodipinmaleat mit mindestens
einem pharmazeutisch annehmbaren Hilfsstoff zur Bildung einer Mischung;
das Entnehmen einer Probe der Mischung;
das Untersuchen dieser Probe, um ein Proben-Analysenergebnis zu erhalten; und
das Vergleichen des Proben-Analysenergebnisses mit einem entsprechenden Referenzstandard-Analysenergebnis für Amlodipinaspartat oder Amlodipinmaleamid, um die Menge an Amlodipinaspartat oder Amlodipinmaleamid relativ zum Amlodipinmaleat zu bestimmen; und
entweder (a) das Abfüllen der Mischung in Kapseln oder (b) das Verpressen der Mischung zu Tabletten.
2. Zusammensetzung nach Anspruch 1, wobei der vergleichende Schritt eine elektronisch gespeicherte Wiedergabe des Referenzstandard-Analysenergebnisses umfaßt.
3. Zusammensetzung nach Anspruch 1 oder 2, wobei der vergleichende Schritt die visuelle Prüfung des Proben-Analysenergebnisses und des Referenzstandard-Analysener­ gebnisses umfaßt.
DE20116639U 2000-12-29 2001-10-11 Referenzstandards zur Bestimmung der Reinheit oder der Stabilität von Amlodipinmaleat Ceased DE20116639U1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25860100P 2000-12-29 2000-12-29
US80934701A 2001-03-16 2001-03-16
BE2001/0713A BE1014456A6 (nl) 2000-12-29 2001-11-05 Referentiestandaarden voor het bepalen van de zuiverheid of stabiliteit van amlodipinemaleaat en werkwijzen daarvoor.

Publications (1)

Publication Number Publication Date
DE20116639U1 true DE20116639U1 (de) 2002-01-17

Family

ID=29740329

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20116639U Ceased DE20116639U1 (de) 2000-12-29 2001-10-11 Referenzstandards zur Bestimmung der Reinheit oder der Stabilität von Amlodipinmaleat

Country Status (12)

Country Link
US (1) US6830933B2 (de)
EP (1) EP1346214A2 (de)
BE (1) BE1014456A6 (de)
CA (2) CA2433284A1 (de)
DE (1) DE20116639U1 (de)
DK (2) DK200300349U3 (de)
FI (1) FI6789U1 (de)
GB (1) GB2371862B (de)
GR (1) GR1004672B (de)
HU (1) HUP0105457A3 (de)
IE (1) IES20011106A2 (de)
WO (1) WO2002054062A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005886A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
CA2433193C (en) 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
GB0114709D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
WO2008107887A2 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
AU2008231470A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
AU2008243749B2 (en) * 2007-05-01 2012-05-03 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
BRPI0811687A2 (pt) * 2007-06-18 2015-02-18 Chemagis Ltd MÉTODO PARA SEPARAR O ISÔMETRO 1R-CIS, 1'R-CIS (cisatracúrio) DE UMA MISTURA DE ISÔMEROS DE SAIS DE (1R, 1'R) - ATRACÚRIO
BRPI0812625A2 (pt) * 2007-07-09 2019-02-19 Chemagis Ltd processo para preparar um sal de cis-atracúrio
EP2197848A1 (de) * 2007-10-29 2010-06-23 Chemagis Ltd. Neuartige r,r'-atracurium-salze
CA2722651A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
CZ20031779A3 (cs) 2000-12-29 2004-10-13 Bioorganicsáb@V Způsob přípravy amlodipinuŹ jeho derivátů a jejich prekurzorů

Also Published As

Publication number Publication date
HU0105457D0 (en) 2002-02-28
GB2371862A (en) 2002-08-07
US20020137223A1 (en) 2002-09-26
BE1014456A6 (nl) 2003-10-07
DK200300349U3 (da) 2004-03-12
CA2433284A1 (en) 2002-07-11
GR20010100601A (el) 2002-10-09
WO2002054062A2 (en) 2002-07-11
GB0131113D0 (en) 2002-02-13
HUP0105457A2 (en) 2002-10-28
GR1004672B (el) 2004-09-13
HUP0105457A3 (en) 2003-12-29
IES20011106A2 (en) 2002-12-30
FIU20030477U0 (fi) 2003-12-17
EP1346214A2 (de) 2003-09-24
US6830933B2 (en) 2004-12-14
DK200300348U1 (da) 2003-12-12
DK200300348U4 (da) 2004-04-23
GB2371862B (en) 2004-07-14
WO2002054062A3 (en) 2003-05-22
CA2366398A1 (en) 2002-06-29
FI6789U1 (fi) 2005-09-14

Similar Documents

Publication Publication Date Title
DE20116639U1 (de) Referenzstandards zur Bestimmung der Reinheit oder der Stabilität von Amlodipinmaleat
CA2102417A1 (en) Determination of glycated hemoglobin by fluorescence quenching
DE3608883C1 (de) Chromatographische Saeule fuer immunologische Untersuchungsverfahren
DE3037595C2 (de) Vorrichtung zur Erzeugung einer Aussparung in einem Betonfertigteil
DE2601918A1 (de) Verfahren und vorrichtung zur messung des kohlendioxidgehaltes eines biologischen fluids
DE2628797A1 (de) Vorrichtung zur automatischen messung und anzeige der absorbtionszeit des schaumes bei fluessigkeiten
DE293269C (de)
DE4139175A1 (de) Elektrolythalter
Greco Ion-Pair High-Performance Liquid Chromatographic Determination of Chlorpheniramine Maleate in Cough-Cold Mixtures
CN206591687U (zh) 一种立柱结构及其组合式隔间
CN212872410U (zh) 一种牛奶蛋白质含量检测装置
CN214472172U (zh) 一种酸性物质的样品制备装置
EP0385173A1 (de) Nichtdispersiver Infrarot-Gasanalysator
Kibby Key to blackening species of Russula of section Compactae
DE2936277A1 (de) Verfahren und ausruestung zur bestimmung der konzentration von beta -adrenergischen blockern und irgendwelchen aktiven stoffwechselprodukten davon in koerperfluessigkeiten
JPH0541400Y2 (de)
JPS59117906U (ja) 締付けボルト
DE102018131355A1 (de) Gesamtgas-Messvorrichtung mit Formkörper
DE20305070U1 (de) Probenvorbereitungsröhrchen
SU885207A1 (ru) В жущее
DE926028C (de) Koch-, Brat- oder Backgeraet und Verfahren zu seiner Herstellung
DE20207930U1 (de) Kaffeefrischhaltedose mit Portionierer
DE8105037U1 (de) Meßzylinder
DE695811C (de) Verfahren zum Einbrennen von Verankerungsmitteln in künstliche Zähne
DE895068C (de) Verfahren zur Pruefung von Ruettelbeton und zur Herstellung von Betonproben aus Ruettelbeton

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20020221

R165 Request for cancellation or ruling filed
R081 Change of applicant/patentee

Owner name: PFIZER LTD., GB

Free format text: FORMER OWNER: BIOORGANICS B.V., NIJMEGEN, NL

Effective date: 20030313

R081 Change of applicant/patentee

Owner name: PFIZER LTD., GB

Free format text: FORMER OWNER: SYNTHON LICENSING, LTD., LUXEMBOURG, LU

Effective date: 20030812

R165 Request for cancellation or ruling filed
R165 Request for cancellation or ruling filed
R150 Utility model maintained after payment of first maintenance fee after three years

Effective date: 20050202

R168 Utility model cancelled

Effective date: 20070507